A study on the correlation between pregnancy risk factors and birth outcomes
- PMID: 40841750
- PMCID: PMC12371034
- DOI: 10.1038/s41598-025-16775-y
A study on the correlation between pregnancy risk factors and birth outcomes
Abstract
Adverse birth outcomes-including low birth weight (LBW, < 2500 g), preterm birth (PTB, < 37 weeks), and intrauterine growth abnormalities-remain major global public health challenges, particularly in low- and middle-income countries. Although maternal body mass index (BMI) and gestational weight gain (GWG) are established risk factors in Western populations, their interactions with metabolic and sociodemographic factors in Asian cohorts, particularly within China's rapidly urbanizing populations, warrant further investigation. This prospective cohort study analyzed 1,026,294 singleton pregnancies (2012-2018) from the Liaoning Maternal and Child Health Information System. Using multivariate logistic regression models, we calculated adjusted risk ratios (RR) with 95% confidence intervals (CI) to evaluate associations between prenatal exposures… and birth outcomes: low birth weight (LBW), macrosomia (> 4000 g), Small-for-gestational-age (SGA, < 10th percentile), Large-for-gestational-age (LGA, > 90th percentile), PTB. Pre-pregnancy underweight (RR = 1.58, 95% CI 1.47-1.70), insufficient gestational weight gain (RR = 1.44, 95% CI 1.36-1.53), and preeclampsia (RR = 3.61, 95% CI 3.18-4.10) were strongly associated with low birth weight. For SGA, pre-pregnancy underweight (RR = 1.68, 95% CI 1.62-1.74) and insufficient GWG (RR = 1.40, 95% CI 1.29-1.51) were key predictors. Conversely, pre-pregnancy obesity (RR = 2.79, 95% CI 2.72-2.85) and excessive GWG (RR = 2.15, 95% CI 2.07-2.23) elevated macrosomia risk. PTB was strongly associated with pre-pregnancy obesity (RR = 1.29, 95% CI 1.25-1.33), assisted reproductive conception (RR = 3.39, 95% CI 3.01-3.83), and early-pregnancy hyperglycemia (RR = 1.19, 95% CI 1.15-2.22). Pre-pregnancy BMI, gestational weight gain (GWG), hypertensive disorders, and metabolic markers (e.g., fasting glucose, hemoglobin) constitute critical modifiable determinants of adverse birth outcomes. These findings quantify region-specific risk thresholds (e.g., 38.1% pre-pregnancy overweight/obesity vs. national 24.8%, Liaoning macrosomia 11.62% vs. national 8.9%) to prioritize GWG monitoring and metabolic screening in Northeast China's urban transition.
Keywords: Adverse birth outcomes; Gestational weight gain; Maternal BMI; Metabolic risk factors; Population-based cohort; Preterm birth.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: The study was approved by the Ethics Committee of Liaoning Maternal and Child Health Hospital (No.20220318001). Exemption from informed consent statement: In this project, data on pregnancy, childbirth, and child growth and development from the Liaoning Maternal and Child Health Service Information System will be used for research. Although this study utilized identifiable human body materials or data for research, it is no longer possible to locate the subject. Therefore, it is impossible or impractical to exempt the subject from informed consent in this study. Therefore, we apply for exemption from informed consent. All methods were performed in accordance with the relevant guidelines and regulations.
Similar articles
-
Preconception hypoglycemia and adverse pregnancy outcomes in Chinese women aged 20-49 years: A retrospective cohort study in China.PLoS Med. 2025 Jul 29;22(7):e1004667. doi: 10.1371/journal.pmed.1004667. eCollection 2025 Jul. PLoS Med. 2025. PMID: 40729125 Free PMC article.
-
The effects of China-recommended gestational weight gain guidelines and the Institute of Medicine guidelines on adverse birth outcomes: A population- based cohort study.Eur J Clin Nutr. 2025 Jul;79(7):667-675. doi: 10.1038/s41430-025-01576-3. Epub 2025 Mar 10. Eur J Clin Nutr. 2025. PMID: 40065104
-
Association between gestational age-specific weight gain in pregnancy and risk of adverse perinatal outcomes: a secondary analysis of the INTERBIO-21st Fetal Study.Am J Clin Nutr. 2025 Jun;121(6):1304-1314. doi: 10.1016/j.ajcnut.2025.04.012. Epub 2025 Apr 16. Am J Clin Nutr. 2025. PMID: 40250762 Free PMC article.
-
Multiple-micronutrient supplementation for women during pregnancy.Cochrane Database Syst Rev. 2017 Apr 13;4(4):CD004905. doi: 10.1002/14651858.CD004905.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 Mar 14;3:CD004905. doi: 10.1002/14651858.CD004905.pub6. PMID: 28407219 Free PMC article. Updated.
-
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2. Cochrane Database Syst Rev. 2018. PMID: 30039871 Free PMC article.
References
-
- Rosenfeld, C. S. Homage to the ‘H’ in developmental origins of health and disease. J. Dev. Org Health Dis.8 (1), 8–29 (2017). - PubMed
-
- Drife, J. O. Fifty years of obstetrics and gynaecology[J]. Br. J. Hosp. Med.77 (Sup10), 572–574 (2016). - PubMed
-
- Metzger, B. E. et al. HAPO study cooperative research group.hyperglycemia and adverse pregnancy outcome study: neonatal glycemia.pediatrics.2010;126 (6):e1545–e1552 . - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical